Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2017 3
2020 5
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Denosumab for cancer-related bone loss.
Dell'Aquila E, Armento G, Iuliani M, Simonetti S, D'Onofrio L, Zeppola T, Madaudo C, Russano M, Citarella F, Ribelli G, Pantano F, Vincenzi B, Tonini G, Santini D. Dell'Aquila E, et al. Among authors: ribelli g. Expert Opin Biol Ther. 2020 Nov;20(11):1261-1274. doi: 10.1080/14712598.2020.1814731. Epub 2020 Sep 9. Expert Opin Biol Ther. 2020. PMID: 32835531 Review.
Current and Emerging Biomarkers Predicting Bone Metastasis Development.
Iuliani M, Simonetti S, Ribelli G, Napolitano A, Pantano F, Vincenzi B, Tonini G, Santini D. Iuliani M, et al. Among authors: ribelli g. Front Oncol. 2020 Jun 3;10:789. doi: 10.3389/fonc.2020.00789. eCollection 2020. Front Oncol. 2020. PMID: 32582538 Free PMC article. Review.
Determinants of bone specific metastasis in prostate cancer.
Manca P, Pantano F, Iuliani M, Ribelli G, De Lisi D, Danesi R, Del Re M, Vincenzi B, Tonini G, Santini D. Manca P, et al. Among authors: ribelli g. Crit Rev Oncol Hematol. 2017 Apr;112:59-66. doi: 10.1016/j.critrevonc.2017.02.013. Epub 2017 Feb 16. Crit Rev Oncol Hematol. 2017. PMID: 28325265 Review.
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
Russano M, Napolitano A, Ribelli G, Iuliani M, Simonetti S, Citarella F, Pantano F, Dell'Aquila E, Anesi C, Silvestris N, Argentiero A, Solimando AG, Vincenzi B, Tonini G, Santini D. Russano M, et al. Among authors: ribelli g. J Exp Clin Cancer Res. 2020 May 27;39(1):95. doi: 10.1186/s13046-020-01601-2. J Exp Clin Cancer Res. 2020. PMID: 32460897 Free PMC article. Review.
Emerging drugs for the treatment of bone metastasis.
Pantano F, Iuliani M, Zoccoli A, Fioramonti M, De Lisi D, Fioroni I, Ribelli G, Santoni M, Vincenzi B, Tonini G, Santini D. Pantano F, et al. Among authors: ribelli g. Expert Opin Emerg Drugs. 2015;20(4):637-51. doi: 10.1517/14728214.2015.1062876. Epub 2015 Jun 25. Expert Opin Emerg Drugs. 2015. PMID: 26113304 Review.
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions.
Pantano F, Croset M, Driouch K, Bednarz-Knoll N, Iuliani M, Ribelli G, Bonnelye E, Wikman H, Geraci S, Bonin F, Simonetti S, Vincenzi B, Hong SS, Sousa S, Pantel K, Tonini G, Santini D, Clézardin P. Pantano F, et al. Among authors: ribelli g. Oncogene. 2021 Feb;40(7):1284-1299. doi: 10.1038/s41388-020-01603-6. Epub 2021 Jan 8. Oncogene. 2021. PMID: 33420367 Free PMC article.
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
Russano M, Napolitano A, Ribelli G, Iuliani M, Simonetti S, Citarella F, Pantano F, Dell'Aquila E, Anesi C, Silvestris N, Argentiero A, Solimando AG, Vincenzi B, Tonini G, Santini D. Russano M, et al. Among authors: ribelli g. J Exp Clin Cancer Res. 2020 Jun 24;39(1):120. doi: 10.1186/s13046-020-01615-w. J Exp Clin Cancer Res. 2020. PMID: 32580740 Free PMC article.
16 results